Ensign Peak Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
Ensign Peak Advisors's RGEN Position: Q3 2026 in Review
Ensign Peak Advisors reduced its Repligen (RGEN) stake by 0.06% in Q3 2026, selling an estimated $6.34K and leaving 69,648 shares worth $13.4M. The position accounts for 0.02% of the portfolio, ranked #396.
Ensign Peak Advisors first reported a position in RGEN in Q4 2019 and has held it in 28 quarters since. The position peaked at $20.7M in Q3 2024. 403 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- Ensign Peak Advisors held 69,648 shares of Repligen worth $13.4M as of Q3 2026.
- Ensign Peak Advisors sold 39 Repligen shares in Q3 2026, an estimated $6.34K.
- Repligen made up 0.02% of Ensign Peak Advisors's portfolio in Q3 2026, its #396 holding.
- Ensign Peak Advisors first reported a position in Repligen in Q4 2019 and has held it in 28 quarters since.
- Ensign Peak Advisors's Repligen position peaked at $20.7M in Q3 2024.
- 403 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on Ensign Peak Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.